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INDEPENDENT SCIENTIFIC ADVISORY COMMITTEE (ISAC) PROTOCOL APPLICATION FORM 
 
PART 1: APPLICATION FORM 
 
IMPORTANT 
Both parts of this application must be completed in accordance with the guidance note ‘Completion of the 
ISAC Protocol Application Form’, which can be found on the CPRD website cprd.com/research-applications  
 
FOR ISAC USE ONLY 
Protocol No. -  Submission date -  
 
 
GENERAL INFORMATION ABOUT THE PROPOSED RESEARCH STUDY 
1. Study Title (Max. 255 characters) 
The effect of common infections on the risk of dementia in individuals with and without diabetes: a cohort study 
using UK primary and secondary care data 
2. Research Area (place ‘X’ in all boxes that apply) 
 
Drug Safety  Economics  
Drug Utilisation  Pharmacoeconomics  
Drug Effectiveness  Pharmacoepidemiology  
Disease Epidemiology X Methodological  
Health Services Delivery    
 
3. Chief Investigator 
 
Title: Dr 
Full name: Charlotte Warren-Gash 
Job title: Associate Professor of Epidemiology/ Wellcome 
Intermediate Clinical Fellow 
Affiliation/organisation: London School of Hygiene and Tropical Medicine 
Email address:  
CV Number (if applicable):  
  
4. Corresponding Applicant 
 
Title: Ms 
Full name: Rutendo Muzambi 
Job title: PhD Student 
Affiliation/organisation: London School of Hygiene and Tropical Medicine 
Email address:  
CV Number (if applicable):  
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5. List of all investigators/collaborators 
 
Title: Ms 
Full name: Rutendo Muzambi 
Job title: PhD Student 
Affiliation/organisation: London School of Hygiene and Tropical Medicine 
Email address:  
CV Number (if applicable):  
Will this person be analysing the data? (Y/N) Y 
 
Title: Professor  
Full name: Liam Smeeth 
Job title: Professor of Clinical Epidemiology 
Affiliation/organisation: London School of Hygiene and Tropical Medicine 
Email address:  
CV Number (if applicable):  
Will this person be analysing the data? (Y/N) N 
 
Title: Professor 
Full name: Krishnan Bhaskaran 
Job title: Professor in statistical epidemiology and Sir Henry Dale 
fellow 
Affiliation/organisation: London School of Hygiene and Tropical Medicine 
Email address:  
CV Number (if applicable):  
Will this person be analysing the data? (Y/N) N 
 
Title: Professor 
Full name: Carol Brayne 
Job title: Director of the Cambridge Institute of Public Health  
Affiliation/organisation: Cambridge University 
Email address:  
CV Number (if applicable):  
Will this person be analysing the data? (Y/N) N 
 
Title: Professor 
Full name: Nish Chaturvedi 
Job title: Professor of Clinical Epidemiology 
Affiliation/organisation: University College London 
Email address:  
CV Number (if applicable):  
Will this person be analysing the data? (Y/N) N 
 
 
6. Experience/expertise available 
 
List below the member(s) of the research team who have experience with CPRD data. 
Name: Protocol Number/s: 
Dr Charlotte Warren-Gash 17_176R, 18_134R, 19_096 
Professor Liam Smeeth 12_027RA, 12_065, 15_257, 16_174, 16_113A, 18_207, 
18_278 
Professor Krishnan Bhaskaran 12_090, 10_097, 12_044, 12_027, 16_174, 16_113A 
 
List below the member(s) of the research team who have statistical expertise. 
Name(s):  
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List below the member(s) of the research team who have experience of handling large datasets (greater than 1 
million records). 
Name(s):  
Professor Krishnan Bhaskaran 
Professor Liam Smeeth 
 
 
List below the member(s) of the research team, or supporting the research team, who have experience of 
practicing in UK primary care. 
Name(s):  
Ms Rutendo Muzambi 
Professor Liam Smeeth 
   
ACCESS TO THE DATA  
7. Sponsor of the study 
 
Institution/Organisation: London School of Hygiene and Tropical Medicine  
Address: Keppel Street, London, WC1E 7HT  
  
8. Funding source for the study 
 
Same as Sponsor? Yes  No X  
Institution/Organisation: Alzheimer’s Society 
Address: Alzheimer's Society, 43-44 Crutched Friars, London, EC3N 2AE 
  
9. Institution conducting the research  
 
Same as Sponsor? Yes X No   
Institution/Organisation: London School of Hygiene and Tropical Medicine 
Address: Keppel Street, London, WC1E 7HT 
  
10. Data Access Arrangements 
 
Indicate with an ‘X’ the method that will be used to access the data for this study: 
Study-specific Dataset Agreement  
 
Institutional Multi-study Licence X  
Institution Name London School of Hygiene and Tropical Medicine 
Institution Address Keppel Street, London, WC1E 7HT 
 
Will the dataset be extracted by CPRD? 
Yes  No X 
 
If yes, provide the reference number: 
 
11. Data Processor(s): 
 
Processing X  
Accessing X 
Storing X 
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Processing area (UK/EEA/Worldwide) UK 
Organisation name London School of Hygiene and Tropical Medicine 
Organisation address Keppel Street, London, WC1E 7HT 
 
[Add more processors as necessary by copy and pasting a new table for each processor] 
  
INFORMATION ON DATA 
12. Primary care data (place ‘X’ in all boxes that apply) 
 
CPRD GOLD X CPRD Aurum  
X 
13. Please select any linked data or data products being requested 
 
Patient Level Data (place ‘X’ in all boxes that apply) 
 
ONS Death Registration Data 
 
 CPRD Mother Baby Link  
HES Admitted Patient Care 
 
X Pregnancy Register  
HES Outpatient  NCRAS (National Cancer Registration and 
Analysis Service) Cancer Registration Data 
 
HES Accident and Emergency  NCRAS Cancer Patient Experience Survey 
(CPES) data 
 
HES Diagnostic Imaging Dataset  NCRAS Systemic Anti-Cancer Treatment 
(SACT) data 
 
HES PROMS (Patient Reported Outcomes 
Measure) 
 NCRAS National Radiotherapy Dataset 
(RTDS) data 
 
  Mental Health Services Data Set (MHDS) 
 
 
   
Area Level Data (place ‘X’ in all boxes that apply) 
 
Practice level (UK)  Patient level (England only)  
Practice Level Index of Multiple Deprivation 
(Standard) 
X Patient Level Index of Multiple Deprivation X 
Practice Level Index of Multiple Deprivation 
(Non-standard) 
 Patient Level Townsend Score  
Practice Level Index of Multiple Deprivation 
Domains (Non-standard) 
   
Practice Level Carstairs Index for 2011 
Census (Excluding Northern Ireland) 
(Standard) 
   
2011 Rural-Urban Classification at LSOA 
level (Non-standard) 
   
 
Reference number (where applicable): 
 
14. Are you requesting linkage to a dataset not listed above? 
 
Yes  No X 
 
If yes, provide the reference number:  
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15. Does any person named in this application already have access to any of these data in a patient 
identifiable form, or associated with an identifiable patient index? 
 
Yes  No X 
 
If yes, provide further details:  
 
VALIDATION/VERIFICATION 
16. Does this protocol describe an observational study using purely CPRD data? 
 
Yes X No  
 
 
17. Does this protocol involve requesting any additional information from GPs, or contact with 
patients?  
 
Yes  No X 
 
 If yes, provide the reference number:  
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PART 2: PROTOCOL INFORMATION 
 
Applicants must complete all sections listed below 
Sections which do not apply should be completed as ‘Not Applicable’ and justification provided 
A. Study Title (Max. 255 characters) 
The effect of common infections on the risk of dementia in individuals with and without diabetes: A cohort study 
using UK primary and secondary care data 
B. Lay Summary (Max. 250 words) 
 
Dementia is a major public health burden posing a devastating impact on individuals, caregivers and healthcare 
services. In the UK, it was estimated that around 850,000 people were living with dementia in 2015 and this number 
is projected to rise to over 1 million by 2025. Due to the rising ageing population and lack of medications that can 
cure or prevent dementia, it has become increasingly important to identify factors that can reduce the risk of 
dementia. Over, the last few decades, there has been growing interest on the role of infections on the risk of 
dementia. However, it remains unclear whether people with common infections such as pneumonia and urinary 
tract infections, have a higher chance of developing dementia. Additionally, common infections frequently occur in 
people with diabetes, and in turn diabetes is associated with dementia. 
 
Therefore, we aim to carry out a study where we will follow individuals over time using anonymous data from 
primary care and hospital health records to investigate whether people with common infections are at an increased 
risk of developing dementia and whether this risk differs in people with and without diabetes. Infections and 
diabetes are potentially preventable and therefore a better understanding of how these conditions affect the risk of 
dementia could lead to important public health interventions. These interventions may include strategies to increase 
the uptake of vaccines to prevent infections, and early recognition and treatment of infections in people with 
diabetes to reduce the risk of developing dementia. 
 
C. Technical Summary (Max. 300 words) 
 
Dementia poses a significant burden on disability and dependence worldwide. Due to the increasing ageing 
population and absence of pharmacological therapies that can delay the onset or progression of dementia, 
dementia risk reduction has become a public health priority. Recent evidence suggests that the incidence of 
dementia is declining in Europe and the USA, and this change has been partly attributed to modifiable risk factors. 
Common infections have been identified as potential risk factors for dementia. In turn, common infections are more 
prevalent in diabetes, which is a strong risk factor for dementia. We hypothesise that individuals diagnosed with 
common infections (lower respiratory tract, urinary tract, skin and soft tissue infections and sepsis) will have an 
increased risk of dementia, and that this risk will increase in individuals with diabetes compared to those without 
diabetes.   
 
To test this hypothesis, we will carry out a cohort study of older adults aged 65 years and over using prospectively 
collected CPRD data linked to hospital episode statistics. We will exclude individuals with prevalent dementia and 
cognitive impairment at baseline. We will assess the age-specific incidence rates of dementia in individuals with and 
without common infections. Then, we will use Cox regression models to investigate the effect of the type, timing and 
frequency of infections on the incidence of dementia, adjusting for confounding factors. We will then investigate the 
presence of effect modification by diabetes on the association between common infections and incident dementia. 
Finally, we will investigate whether there is an association between common infections and evidence of cognitive 
impairment. To the test the robustness of our findings, we will carry out a range of sensitivity analyses. Improved 
understanding of the interrelationship between infections and diabetes with incident dementia will help to inform 
dementia risk reduction interventions. 
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D. Outcomes to be Measured 
 
Primary Outcomes 
(1) Incidence of dementia (all types)  
(2) Incident dementia (type-specific Alzheimer’s disease, vascular, mixed, other).  
 
Secondary Outcome 
(1) Evidence of cognitive impairment 
 
Objectives, Specific Aims and Rationale 
 
Objective 
The objective of this study is to investigate the effect of common infections (lower respiratory tract, urinary tract and 
skin and soft tissue infections and sepsis) on the incidence of dementia in adults aged 65 years and older and 
whether this risk varies in individuals with and without diabetes, using CPRD data linked to HES.  
 
Specific aims 
1. To describe the age-specific incidence rates of dementia in adults aged 65 years and older with and without 
common infections. 
2. To investigate whether the presence, frequency, timing and type of common infections affect the risk of 
dementia. 
3. To investigate whether diabetes modifies any association between common infections and incident 
dementia. 
4. To investigate whether the presence or type of common infections are associated with evidence of 
cognitive impairment (secondary outcome).  
 
Rationale 
Identifying modifiable risk factors for dementia has become increasingly important given the increasing burden of 
dementia. As a result, dementia risk reduction is a public and global health priority. If diabetes and common 
infections interact to increase the risk of developing dementia, these potentially preventable conditions could be a 
target to reduce the risk of dementia. 
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E. Study Background 
 
Dementia is a major public health challenge. With the global prevalence projected to rise from 47.5 million in 2015 
to 135.5 million by 2050, the burden of dementia on individuals, caregivers and healthcare services is set to rise 
markedly [1]. Currently, there are no pharmacological therapies that can delay the onset or progression of dementia 
and as the ageing population continues to rise, dementia risk reduction has become a public health priority [2]. 
 
Recently, a large multi-area, population-based study from the UK reported a 20% decrease in the age-specific 
incidence of dementia in adults aged 65 years and older [3]. Other population based studies from Europe and the 
US have reported a declining trend in the age-specific incidence of dementia among older adults, [4-9] with 
improvements in education and vascular risk factors partly accounting for this change [10]. Therefore, identification 
of risk factors for dementia could play an important role in risk reduction. Although the single biggest predictor of 
dementia is age[11], a non-modifiable risk factor, population-based cohort studies have shown that addressing 
modifiable risk factors can reduce the risk of dementia by a third [12-14]. These risk factors include smoking, 
hypertension, education, socioeconomic status and diabetes. 
 
Over the last few decades, there has been a large body of evidence to suggest that infections play a role in the risk 
of dementia. Pathological evidence has demonstrated the prevalence of bacterial, viral and fungal infections in 
individuals with Alzheimer’s disease [15-17]. However, due to the cross-sectional nature of these studies, the ability 
to assess temporality or to make any inferences about causality is limited. Acute infections are well known to 
precipitate short term changes in cognition. However, the association of these infections with long term cognitive 
impairment is less established. Findings from a US prospective study of older adults showed that individuals 
hospitalised with sepsis, an acute life threatening infection, were likely to develop moderate to severe cognitive 
impairment [18]. In turn, cognitive impairment is a strong predictor for dementia [19].  
 
Common infections such as pneumonia and urinary tract infections, have been shown to be prevalent in individuals 
with dementia [20, 21]. Few longitudinal studies have investigated the role of these infections on the incidence of 
dementia. Two of these studies were insufficiently powered and focused only on patients hospitalised with 
pneumonia, limiting their ability to capture patients with less severe infections [22] [23]. A large scale retrospective 
study of US veterans (N=417,172) found that the incidence of dementia was increased by the following infections: 
pneumonia (HR 1.10 95% CI 1.02-1.19), urinary tract infections (HR 1.13 95% CI 1.08-1.18), cellulitis (HR 1.14 
95% CI 1.09-1.20) and sepsis  [24]. However, the generalisability of the findings was restricted to males and military 
veterans, and as with the two aforementioned studies, the study was conducted in the US, limiting generalisability 
to other countries.  Recently, a large-scale population-based study of over 60,000 individuals using a Taiwanese 
longitudinal health insurance database showed that individuals with a history of sepsis were at a greater risk of 
developing dementia compared to those without sepsis. However, the majority of these studies did not investigate a 
range of common infections within the same study and none of these studies examined the effects of multiple 
episodes of infection on the incidence of dementia. Additionally, although a longitudinal study using UK primary 
care data found that episodes of infection were associated with an increased likelihood of a diagnosis of dementia 
in elderly adults aged 84 years or older [25], no studies in the UK have specifically investigated the association 
between types and frequency of common infections with incident dementia.  
 
Infections frequently occur in people with diabetes [26]. In a recent systematic review of cohort and case control 
studies, diabetes was associated with an increased incidence of infections including respiratory, genitourinary and 
skin infections [27]. Additionally, two studies using data from UK electronic health records showed that individuals 
with diabetes were at an increased risk of infections compared to the general population [28] [29]. Diabetes is a 
well-known risk factor for dementia. In a recent systematic review and meta-analysis of 14 prospective studies from 
2.3 million people, diabetes was associated with a 60% increased risk of dementia overall [30]. These findings were 
consistent with two previous meta-analyses of longitudinal studies [31] [32].  Given the co-occurrence of infections 
and diabetes, and their association with dementia, it is possible that diabetes could modify the effect of common 
infections on the risk of dementia.  
 
To our knowledge, no studies have investigated the potential interaction between diabetes and infections on the 
incidence of dementia. Diabetes and infections are both major health conditions that pose a significant impact on 
public health services. As both conditions are potentially preventable, understanding their association with dementia 
could have public health implications in targeting populations at an increased risk of dementia and early treatment 
of infections and diabetes could reduce the risk and burden of dementia.  
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Therefore, our aim is to investigate the effect of common infections on the risk of dementia and to investigate 
whether this effect varies in individuals with and without diabetes, using a large dataset of primary care records 
linked to hospital episode statistics (HES), representative of the UK population. We will also investigate the 






F. Study Design 
Historical cohort study using CPRD data and linked HES data 
G. Feasibility counts 
 
• There were 1,009, 629 individuals aged 65 years and older in CPRD with linked HES data between 2004 
and 2018 with at least 12 months research standard follow up and no prior history of dementia. 16.4% had 
any common infection. 
• 11.4% had a lower respiratory tract infection, 0.7% had sepsis, 3.1% had a urinary tract infection and 4.2% 
had a skin and soft tissue infection. The median follow-up time was 12.7 years. 82% had more than 5 years 
of follow up. 
• 4.7% (n=47589) developed dementia.  
• The incidence of dementia in adults aged 65 years and older in the UK has been estimated to be around 
209,600 new cases of dementia per year [3]. As dementia is underdiagnosed in primary care, it is likely that 
the incidence of dementia will be lower in CPRD. 
 
H. Sample size considerations 
 
We used the results of our feasibility counts to carry out our sample size calculations. Here we calculated the 
minimum effect estimate for common infections on the risk of dementia. Our estimates are conservative as we 
estimated that 16.4% of our study population had a first ever common infection and 4.7% of our total population 
developed dementia. 
 
From our feasibility counts, we estimated that we would have 5 people unexposed to infections for every person 
with an infection. Hence, we will have an 80% power at a 5% significance level to detect a minimum hazard ratio of 
1.02.  
 
I. Planned use of linked data (if applicable): 
 
We plan to use primary care data from CPRD linked to Hospital Episode Statistics. Although dementia cases are 
likely to be diagnosed in primary care settings, using HES will help to identify additional cases and improve the 
accuracy of information available on timing of dementia diagnosis. We will also identify infections using linked HES 
data: a recent UK study comparing incidence of community acquired pneumonia in primary and secondary care 
data among adults aged 65 years and older found that the incidence estimates of community acquired pneumonia 
were 28% lower in primary care data alone compared to linked data [33].  
 
We also plan to use patient-level IMD and practice-level IMD as a measure of socioeconomic deprivation, which is 
a potential confounding factor. Our primary analysis will include only individuals with linked data, and therefore we 
plan to use patient-level IMD for this analysis. We will consider practice-level IMD for the sensitivity analysis which 
includes individuals without linked data. 
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J. Definition of the Study population 
 
We will include all adults aged 65 years and older present in CPRD (Gold) with linked HES data, who were 
registered in CPRD between 1st January 2004 and 31 December 2018. We will include individuals with at least 12 
months of research standard follow up in CPRD. Therefore, follow up will begin at the latest of 01/01/2004, 65th 
birthday or 12 months after research standard follow up.  
 
We will follow individuals to the earliest of: incident dementia diagnosis, date of death, transfer out date, the 
practice’s last data collection date or end of study period. 
 
Exclusion 
We will exclude individuals with a history of dementia and cognitive impairment. To account for delirium, which is an 
acute complication of common infections, we will exclude the first 3 months after infection.   
 
K. Selection of comparison group(s) or controls 
 
The comparison group will comprise of adults aged 65 and over unexposed to common infections during the study 
period.  
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We will identify Read codes and ICD-10 codes of common infections in both CPRD and HES data.  
Common infections can result in short term reversible changes in cognition, delirium, as a result it is possible that 
individuals diagnosed with dementia shortly after infection could have been experiencing delirium and were 
misdiagnosed as having dementia. Therefore, the reduce the risk of misclassifying delirium as dementia, we will 













Our exposure will reflect an ever diagnosis of infection. This will mean that individuals can move from the 
unexposed group to exposed but once diagnosed with infection they cannot move to the unexposed group. 
 
Exposure will be defined as one of the following: 
1. A clinical code for lower respiratory tract infections 
2. A clinical code for sepsis 
3. A clinical code for urinary tract infections and a prescription for antibiotics 
4. A clinical code for soft tissue infections and a prescription for antibiotics  
 
We will group all common infections (lower respiratory tract, urinary tract, skin and soft tissue infections and sepsis) 
into one category ‘any infection’ in order to determine the overall association of common infections with incident 
dementia. Then we will group infections according to subtype of infection. Each subtype of infection will be further 





Our primary outcome will be defined as first ever dementia diagnosis. Incident dementia will be identified using 
Read codes for dementia (any dementia subtype) and ICD-10 codes in HES data. We will exclude those with a prior 




Evidence of cognitive impairment 
Our secondary outcome will be defined as first ever evidence of cognitive impairment. We will identify cognitive 
impairment using Read codes and ICD-10 codes in CPRD and HES. We will exclude individuals with a prior history 




• Age (65-69, 70-74, 75-79,80-84, 85-89, 90+ using data from CPRD)  
• Sex (male and female using data from CPRD) 
• Ethnicity (White, black, South Asian and other using data from CPRD or HES) 
• Calendar year (2004-2008, 2009-2013, 2014-2018) 





Exclusion of first 3 
months of follow up 
after infection  
Follow up from 3 months 
after infection  
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• BMI, kg/m2 (underweight, <18.5, normal weight 18.5-25, overweight/obese >25 using additional files in 
CPRD) 
• Smoking (Non-smoker, ex-smoker and current smoker using additional files in CPRD) 
• Alcohol consumption (non-drinker, current drinker, heavy drinker, light drinker, moderate drinker and ex 
drinker, using additional files in CPRD) 
• Frequency of health service usage (Information relating to health service usage will be obtained from the 
number of GP consultations and hospitalisations using CPRD and HES) 
 
We will identify read codes relating to the following conditions in clinical, test and therapy files using CPRD and 
HES: 
• Cardiovascular disease: atrial fibrillation, angina, previous myocardial infarction, hypertension, ischemic 
heart disease, congestive heart failure  
• Comorbid conditions: traumatic brain injury, stroke, atherosclerosis, chronic kidney disease, peripheral 
vascular disease, retinopathy, neuropathy, chronic liver disease, asthma, chronic obstructive pulmonary 
disease, epilepsy, Parkinson’s disease, obstructive sleep apnoea and HIV  
• Psychiatric comorbidity: cognitive impairment, post-traumatic stress disorder, major depression, 
schizophrenia, bipolar disorder and anxiety disorder  
• Glycaemic control using HbA1c (<6%, 6-6.5%, 6.5-7%, 8-10% and >10%) 
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M. Data/ Statistical Analysis 
 
Aim 1 
We will describe the age specific incidence rates of dementia in individuals with and without common infections by 
calculating the number of events and person time at risk of dementia. Age will be stratified into the following groups: 
65-69, 70-74, 75-79,80-84, 85-89, 90+.  
 
Aim 2  
We acknowledge that the competing risk of mortality is possible when estimating the risk of dementia, particularly in 
an elderly multimorbid population, and that failure to account for this may lead to biased effect estimates if a 
competing risk analysis approach is not used. However, when addressing aetiological research questions, Cox 
regression is an appropriate method of analysis [34, 35]. Therefore, as we aim to investigate the causal relationship 
between common infections and dementia, we will use Cox regression analysis to estimate the incidence of 
dementia in those exposed and unexposed to any common infection.  Current age will be fitted as the underlying 
time scale. Our final model will adjust for all the confounders listed previously.  
We will then stratify by: 
• type of infections (sepsis, lower respiratory tract, urinary tract, skin and soft tissue infections) and this will 
also include the severity of infections (e.g. hospitalised infections vs non-hospitalised infections or severe 
sepsis) 
• time after infection diagnosis (e.g. 3-12 months, 3-24 months, 3-36 months etc) 
• frequency of infections (e.g. 0 1, 2, >3). 
 
We will consider infections that occur within 28 days of each other as a single episode of infection. 
 
Aim 3 
We will investigate the presence of effect modification by fitting an interaction term of diabetes to our Cox 
regression model and then carrying out likelihood ratio tests.  
 
Aim 4 
We will use Cox regression models to estimate the risk for our secondary outcome of cognitive impairment in those 




1. We will stratify by dementia subtype in order to explore the incidence of dementia according to subtypes of 
dementia (Alzheimer’s disease and vascular dementia).  
2. We will stratify by sex to compare the incidence of dementia in men and women. 
3. We will repeat our primary analyses to include individuals in CPRD without HES linked data. 
4. We will exclude individuals with read codes for dementia that is causally linked with other diseases such as 
‘HIV associated dementia’ and we will instead perform sensitivity analyses only for dementia that is not 
specifically caused by a particular disease.  
5. To more reliably assess whether infections are associated with evidence of cognitive impairment and we 
will exclude individuals with recodes for symptoms of cognitive impairment and instead only include those 
with less ambiguous read codes of cognitive impairment such as ‘mild cognitive impairment’.  
6. We will repeat our primary analyses defining all types of common infections using clinical codes and an 
antibiotic prescription. 
7. We will repeat our primary analyses stratifying according to the time period before death. 
 
N. Plan for addressing confounding 
Our final model will include all potential confounders specified in section K.  
O. Plans for addressing missing data 
We will describe the pattern of missing data present and choose a suitable method for accounting for missing data 
accordingly. We expect to find missing data on smoking and ethnicity. However, since these data are less likely to 
be missing at random, we will most likely use a complete case analysis to carry this out. 
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P. Patient or user group involvement (if applicable) 
This study is funded by the Alzheimer’s Society.  Through the Alzheimer’s society, we have been assigned a group 
of three lay volunteers who will act as research monitors for the present study. We will seek the research monitors 
views on the design and conduct of our study as well as the dissemination of our results.   
Q. Plans for disseminating and communicating study results, including the presence or absence of any 
restrictions on the extent and timing of publication 
 
We will disseminate our findings at relevant conferences, events, meetings and we plan to submit our results for 
publication in a peer reviewed journal. We will work with the Alzheimer’s Society to present our findings to members 
of the public. 
 
Conflict of interest statement: There are no competing interests to declare. 
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R. Limitations of the study design, data sources, and analytic methods 
 
Misclassification of dementia 
There are a number of ways dementia could be misclassified. First, dementia is known to be frequently 
underdiagnosed in primary care with studies suggesting that over 50% of dementia cases are not detected in 
primary care [36] [37], although this has been changing with time across this period as recent evidence now 
suggests that around two thirds of people with dementia have a diagnosis in primary care[38]. Nevertheless, 
misclassification and underestimation of dementia incidence is possible. However, the positive predictive values of 
dementia in CPRD are over 80% and we will link CPRD to HES data which will enable us to capture more dementia 
cases, although this will likely introduce other biases as certain groups such as ethnic minorities and those with 
milder dementia are less likely to be receive a hospital dementia diagnosis [39]. Therefore, misclassification in HES 
is also possible although the recording of dementia in HES has been increasing since 2008 and the sensitivity and 
specificity for each person’s complete hospital records has been estimated to be around 78% and 92%, respectively 
[39]. Second, dementia has a long pre-clinical phase and therefore it is possible that individuals classified as not 
having dementia in CPRD could already be experiencing cognitive decline or already have dementia. In turn, these 
individuals may be more susceptible to having infections. To address this, we will present the hazard ratios for 
incident dementia in different time periods after infection. Additionally, in the period before death, older individuals 
could be at risk of serious cognitive decline which could also increase their likelihood of a dementia diagnosis. As a 
result, we will explore the proximity of dementia diagnosis to death. Lastly, common infections are known to be 
associated with delirium, a serious neuropsychiatric syndrome characterised by acute cognitive dysfunction and 
inattention. It is therefore possible that delirium may be misclassified as dementia. To reduce this, we will exclude 
all dementia cases occurring within 3 months after an infection. Additionally, we acknowledge that dementia 
diagnosed shortly after infection, even after delirium has resolved, is less likely to be causally linked to infection due 
to the long pre-clinical phase of dementia.  
 
Misclassification of cognitive impairment 
Read codes for cognitive impairment have not been validated in CPRD and thus misclassification is possible.  
Read codes related to cognitive impairment may have been assigned without a diagnostic test and it is possible that 
individuals who were older and of a lower educational background may have been misclassified as having evidence 
of cognitive impairment. Additionally, individuals in CPRD are unlikely to have had their cognition tested at multiple 
time points, as a result, without a comparison of previous cognitive ability, misclassification of cognitive impairment 
is possible. Furthermore, codes relating to symptoms of cognitive impairment may be inaccurate and may not 
specifically relate to clinical cognitive impairment. To minimise this, we will perform sensitivity analyses for codes 
that indicate a diagnosis of cognitive impairment rather than symptoms of cognitive impairment. 
 
Misclassification of common infections 
There are a number of ways in which misclassification of infections is possible during this study. Firstly, in primary 
care settings, infections are often diagnosed without microbiological data to confirm diagnosis. Secondly, people 
with less serious infections might be less likely to visit the GP which might also lead to an underestimation of people 
with infections. Lastly, it is possible that people who will be unexposed to infections during the study period were 
exposed to common infections before the study which might affect their risk for dementia.  
 
Detection bias 
People with diabetes are more likely to visit health services compared to those without, thus potentially increasing 
their chances of a dementia diagnosis. Diabetes is also a known risk factor for dementia and as such it is possible 
that people with diabetes might be screened more frequently for dementia which might also increase their chances 
of a dementia diagnosis. Recently, dementia risk has been included in the NHS health checks programme and 
diabetes has been identified as a risk factor for dementia. This might also increase the likelihood of people with 
diabetes to receive a dementia diagnosis. 
 
Missing data 
Missing data on confounding variables such as ethnicity, smoking and education are likely. We will describe the 
pattern of our missing data (whether our data is missing completely at random, missing at random or missing not at 
random) and choose an appropriate method for dealing with the missing data.  
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List of Appendices 
 
1. Provisional code lists for outcomes (CPRD) 
a) Dementia  
b) Cognitive impairment 
 
2. Provisional code lists for exposures (CPRD) 
c) Lower respiratory tract infections 
d) Sepsis 
e) Urinary tract infections and antibiotics 
f) Skin and soft tissue infections and antibiotics 
 
 
 
 
